List

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until April, 2020.

  1. SYNTHESIS OF RNA CANCER VACCINES

    SBC: AMBION DIAGNOSTICS, INC.            Topic: N/A

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  2. SIMULTANEOUS DETECTION OF AT LEAST 100 DIFFERENT MRNAS

    SBC: AMBION DIAGNOSTICS, INC.            Topic: N/A

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  3. POINT DEVICE FOR COMPUTERS WITH NON-RASTER DISPLAYS

    SBC: APPLIED HUMAN FACTORS INC            Topic: N/A

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  4. Semiautomatic, Quantitative Analysis of Funds

    SBC: APPLIED SCIENCES LABORATORY, INC.            Topic: N/A

    N/A

    SBIR Phase II 1996 Department of Health and Human Services
  5. BIOFILM INHIBITING COATING FOR URETHRAL CATHETERIZATION

    SBC: Biomedical Development Corporation            Topic: N/A

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  6. ONE STEP ANTIMICROBIAL SURGICAL PREPARATION AND DRAPE

    SBC: Biomedical Development Corporation            Topic: N/A

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  7. 3D CALCIUM CARBONATE BONE REPLACEMENT MATERIAL

    SBC: BIOMEDICAL ENTERPRISES, INC.            Topic: N/A

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  8. Construction of Synthetic Muscle Specific Promoters

    SBC: Genemedicine, Inc.            Topic: N/A

    Somatic gene therapy is expected to provide new and improved therapies for many diseases.We are developing a new class of DNA-based therapeutics, "gene medicines" which are expected toprovide unique clinical benefits for the treatment of a broad range of diseases. Gene medicines utilizetissue-specific DNA expression vectors and novel vector delivery systems for the in vivo delivery oftherapeutic p ...

    SBIR Phase II 1996 Department of Health and Human Services
  9. Molecular Switch for Controlled Gene Therapy

    SBC: Genemedicine, Inc.            Topic: N/A

    This application describes construction of a vector for a gene therapy that can be incorporatedinto somatic cells in vivo and then regulated by administration of an oral, non-toxic, and widelybioavailable drug. The "gene switch" is based on a derived mutant of the progesterone receptor thatis activated by progesterone antagonists, but is not activated by progesterone agonists or other steroids.Thi ...

    SBIR Phase II 1996 Department of Health and Human Services
  10. GENE MEDICINES FOR HEMOPHILIA B

    SBC: Genemedicine, Inc.            Topic: N/A

    N/A

    SBIR Phase I 1996 Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government